ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

34,637Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 6969

$2.22M Total Retail Price of All Prescriptions

Rank: 23 out of 6969

463 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
100% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

4% of this provider’s 463 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

4% of this provider’s 26,180 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

40% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

75 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
METOPROLOL SUCCINATE 1,237 905 1 22
DIOVAN HCT 905 713 2 57
MELOXICAM 882 612 3 36
SIMVASTATIN 858 607 4 1
CRESTOR 837 612 5 39
IBUPROFEN 802 594 6 29
TRAMADOL HCL 790 622 7 27
GABAPENTIN 773 465 8 17
GLYBURIDE-METFORMIN HCL 744 603 R 9 92
ZOLPIDEM TARTRATE 735 604 10 16
AMLODIPINE BESYLATE 733 569 11 4
ATENOLOL 711 497 12 9
LOVAZA 682 470 13 77
NEXIUM 627 464 14 52
TAMSULOSIN HCL 537 416 15 23
OMEPRAZOLE 515 373 16 6
FAMOTIDINE 495 391 17 37
BACLOFEN 489 314 18 86
SINGULAIR 484 362 19 84
LOSARTAN-HYDROCHLOROTHIAZIDE 446 354 20 53
NAPROXEN 445 313 21 62
FUROSEMIDE 420 386 22 10
METOPROLOL TARTRATE 413 351 23 13
VOLTAREN 412 311 24 105
DEXILANT 407 326 25 110
DICLOFENAC SODIUM 397 207 26 78
ACTOS 378 304 27 61
LISINOPRIL 376 265 28 2
METFORMIN HCL 364 228 29 7
MECLIZINE HCL 358 299 30 100
ALENDRONATE SODIUM 352 270 31 14
ATORVASTATIN CALCIUM 332 211 32 11
DONEPEZIL HCL 325 305 33 32
ZETIA 299 219 34 98
TRIAMCINOLONE ACETONIDE 295 233 35 55
RAMIPRIL 283 236 36 112
CLONIDINE HCL 279 248 37 59
DIOVAN 255 202 38 26
NASONEX 250 189 39 144
AMLODIPINE BESYLATE-BENAZEPRIL 248 205 40 91
PRAVASTATIN SODIUM 238 187 41 19
NAMENDA 238 225 41 51
JANUMET 234 175 43 138
PLAVIX 233 182 44 68
AMITRIPTYLINE HCL 233 161 R 44 87
LIPITOR 216 130 46 89
CLOPIDOGREL 213 174 47 48
CARVEDILOL 200 196 48 25
ISOSORBIDE MONONITRATE ER 198 134 49 81
AVODART 196 168 50 108
FLUOCINONIDE 192 154 51 134
MONTELUKAST SODIUM 190 149 52 151
LEVOTHYROXINE SODIUM 187 134 53 5
EXELON 181 167 54 157
CELEBREX 180 159 55 67
MICARDIS HCT 176 79 56 285
TRAZODONE HCL 169 104 57 47
LANSOPRAZOLE 167 102 58 171
SYMBICORT 161 90 59 149
BENAZEPRIL HCL 157 145 60 18
JANUVIA 156 112 61 41
SERTRALINE HCL 155 128 62 38
VESICARE 155 63 62 163
HYDROXYZINE HCL 154 94 R 64 159
ADVAIR DISKUS 153 128 65 45
NITROSTAT 152 128 66 210
FLUTICASONE PROPIONATE 151 114 67 24
VENLAFAXINE HCL ER 150 126 68 150
CYMBALTA 148 92 69 72
PANTOPRAZOLE SODIUM 148 120 69 31
SPIRIVA 142 103 71 66
HYDROCHLOROTHIAZIDE 130 88 72 8
AZITHROMYCIN 129 94 73 42
PAROXETINE HCL 128 128 74 65
SULINDAC 126 102 75 267
CICLOPIROX 124 84 76 415
GLIMEPIRIDE 124 97 76 44
VYTORIN 122 94 78 148
ESCITALOPRAM OXALATE 121 80 79 93
CYCLOBENZAPRINE HCL 120 36 R 80 130
EVISTA 116 94 81 118
PROAIR HFA 115 87 82 33
LEXAPRO 109 57 83 200
PIOGLITAZONE HCL 107 98 R 84 174
VERAPAMIL ER 106 93 85 133
ROPINIROLE HCL 105 92 86 162
CIPROFLOXACIN HCL 105 75 86 64
JALYN 101 84 88 339
IBANDRONATE SODIUM 101 90 88 178
DIGOXIN 96 87 90 71
NOVOLOG MIX 70-30 93 47 91 324
OXYBUTYNIN CHLORIDE 92 73 92 126
BONIVA 91 67 93 198
BENICAR HCT 89 83 94 176
CILOSTAZOL 88 68 95 208
WARFARIN SODIUM 84 70 96 20
DETROL LA 83 71 97 223
NIASPAN 82 57 98 146
ECONAZOLE NITRATE 82 49 98 290
LANTUS 80 68 100 50
ATELVIA 78 35 101 111
ENALAPRIL MALEATE 78 47 101 56
MOMETASONE FUROATE 77 63 103 361
EFFIENT 77 72 103 272
SUMATRIPTAN SUCCINATE 76 39 105 260
TERAZOSIN HCL 75 63 106 49
ALCOHOL PREP PADS 74 60 107 282
SPIRONOLACTONE 73 68 108 102
PROCTOSOL-HC 71 67 109 364
CREON 71 58 109 147
VALSARTAN-HYDROCHLOROTHIAZIDE 70 56 111 346
ACIPHEX 67 67 112 181
ISOSORBIDE DINITRATE 64 64 113 231
VERAPAMIL ER PM 64 47 113 503
ACTONEL 62 55 115 115
PROMETHAZINE HCL 61 43 R 116 203
SURE COMFORT 61 38 116 263
SINGLE USE SWAB 58 43 118 306
INSULIN SYRINGE 58 48 118 60
POTASSIUM CHLORIDE 55 42 120 30
LIDODERM 54 22 121 75
XOPENEX HFA 53 36 122 350
CARBIDOPA-LEVODOPA 52 52 123 119
AMIODARONE HCL 51 51 124 184
THEOPHYLLINE ANHYDROUS 51 34 124 287
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 24, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.